Cited by 53Sleep and related disordersCancer survivorship and careSleep and Work-Related Fatigue

Living with persistent insomnia after cancer: A qualitative analysis of impact and management

Open access
Reynolds‐Cowie, Paul, Fleming, Leanne·2021·British Journal of Health Psychology

Abstract

Objectives: To conduct a qualitative exploration of the lived experience of insomnia disorder and its management amongst a sample of mixed‐diagnoses cancer survivors. Methods: Twenty‐seven cancer survivors with persistent insomnia were recruited to this qualitative study following completion of treatment for breast (12), prostate (7), colorectal (7), and gynaecological (1) cancers. Eleven males and 16 females (mean age 62 years), who met DSM‐5 criteria for insomnia disorder, contributed to one of four focus group discussions, designed to explore the lived experience of persistent insomnia and its management within cancer care services. Results: Poor sleep was a persistently troubling complaint for participants, long after the completion of active cancer treatment. The impact of insomnia was significant for all participants, with six key domains emerging as those most affected: temperament, sociability, physical well‐being, cognitive functioning, relationships, and psychological well‐being. In terms of insomnia management, participants frequently resorted to unfruitful self‐management strategies, due to the lack of professional insomnia expertise within cancer care settings. Three main themes emerged in relation to insomnia management: self‐management, seeking professional intervention, and a lack of focus on sleep. A lack of clinician understanding of the importance of sleep health and the poor availability of evidence‐based insomnia interventions, such as cognitive behavioural therapy for insomnia (CBT‐i), were highlighted as important gaps in cancer care. Conclusions: Insomnia was found to have a detrimental and pervasive impact on cancer survivors’ quality of life, which persisted long into survivorship. There is an absence of professional attention to sleep throughout the cancer care trajectory, contributing to its prevalence, persistence, and impact. In order to break this cycle, sleep health should be integrated as a key aspect of cancer treatment and rehabilitation, much like maintaining a healthy diet and appropriate levels of physical activity.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/bjhp.12446

Cites

55 of 55 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Pharmacotherapy remains the most pragmatic resource for cancer-related insomnia, despite limited evidence for long-term efficacy, not being curative, side effects (abuse, dependence, tolerance), and security profile (drug-drug and drug-disease interactions).

    “Consequently, pharmacotherapy, a second-line intervention, remains the most pragmatic resource, 4 filling the cancer-related insom -nia treatment gap despite limited evidence for long-term efficacy, not being curative, side effects (including abuse, dependence, and tolerance), and security profile (e.g., drug-drug and drug-disease interactions). 18”

    From Digital Cognitive-Behavioral Therapy for Insomnia in Cancer Survivors: Protocol for a Pragmatic Clinical Trial (2024) · cites this paper as [4]

    Split into 2 atoms — 0 confirmed, 2 partially supported, 0 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.

    Experimental — accuracy not yet measured
  • Insomnia is a prevalent complaint linked to cancer and its treatments, affecting between 29% and 64% of cancer survivors months or years after treatment completion.

    “Insomnia emerges as a prevalent complaint linked to cancer and its treatments, and tends to persist, affecting between 29% to 64% of can -cer survivors months or years after treatment completion. 4-6”

    From Digital Cognitive-Behavioral Therapy for Insomnia in Cancer Survivors: Protocol for a Pragmatic Clinical Trial (2024) · cites this paper as [4]

    The Background and Discussion (page numbers unavailable) describe insomnia as common in people with cancer, amplified by treatment, and persistent into survivorship. They do not support the stated 29%–64% prevalence among survivors months or years after treatment; the Background instead gives 18%–29% for diagnosable insomnia in cancer patients and 70% for disturbed sleep. (LLM, conf=0.88)

    Experimental — accuracy not yet measured
  • The daytime consequences of insomnia typically motivate cancer survivors to seek specialized help.

    “typically motivate survivors to seek specialized help. 4”

    From Digital Cognitive-Behavioral Therapy for Insomnia in Cancer Survivors: Protocol for a Pragmatic Clinical Trial (2024) · cites this paper as [4]

    The Results report substantial consequences of poor sleep, including impaired daytime functioning. In the “I tried to get help” passage, some participants raised poor sleep with a GP or at routine cancer appointments. The paper does not establish that daytime consequences typically motivated survivors to seek specialized help; the help described was not specialized insomnia care. (LLM, conf=0.84)

    Experimental — accuracy not yet measured
  • Insomnia has daytime consequences, including fatigue and mood impairments that affect quality of life.

    “The daytime consequences of insomnia, including fatigue and mood impairments that affect the quality of life”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Reynolds‐Cowie, P., & Fleming, L.
Affiliations
  • Oxford Health NHS Foundation Trust (GB)
  • University of Strathclyde (GB)
Corresponding author
Fleming, Leanne
Venue
British Journal of Health Psychology
Publisher
Wiley
Published
2020-06-17
Volume
26
Issue
1
Pages
33-49
ISSN
  • 1359-107X (ISSN-L)
  • 2044-8287
OpenAlex
W3036217655
Cited by
53
References
55
Citations by year
2026: 7 · 2025: 7 · 2024: 16 · 2023: 8 · 2022: 10 · 2021: 5
FWCI
5.56
Type
journal article
Language
en
Open access
Locations
  • British Journal of Health Psychology (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Strathprints: The University of Strathclyde institutional repository (University of Strathclyde) (submittedVersion)
Topics
  • Social Sciences › Psychology › Experimental and Cognitive Psychology › Sleep and related disorders
  • Health Sciences › Medicine › Oncology › Cancer survivorship and care
  • Social Sciences › Psychology › Experimental and Cognitive Psychology › Sleep and Work-Related Fatigue
Keywords
chronic insomnia, cancer survivors, insomnia management, sleep health, cognitive behavioral therapy for insomnia, self-management strategies, quality of life, psychological well-being, oncology services, sleep interventions, breast cancer, prostate cancer, colorectal cancer, gynecologic cancer
MeSH terms
Cancer Survivors, Female, Humans, Sleep Initiation and Maintenance Disorders, Male, Middle Aged, Neoplasms, Quality of Life, Sleep, Cognitive Behavioral Therapy

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review